PHARMACY

PDX, HDS fuse automation, data with verification tool

BY DSN STAFF

FORT WORTH, Texas — Blending the power of one of the most widely used pharmacy automation systems with a massive database of prescribing physicians, two major pharmacy technology providers have unveiled a new partnership designed to give dispensing pharmacists immediate access to real-time prescriber data.


Retail pharmacy technology provider PDX and Healthcare Data Solutions announced the alliance in November. The goal, according to both companies, is to link users of the PDX Pharmacy System with a real-time prescriber verification process.


The result could give pharmacists an immediate and more accurate check of each patient’s prescription by providing up-to-date information on the doctor who wrote the prescription. Both companies said the integration of the PDX Pharmacy System and the HDS PrescriberPRO database would allow immediate verification of prescribers and associated profiles — including when a prescriber is added or before a prescription is filled.


Retail pharmacists using PDX technology can access PrescriberPRO over a secure, Web-based service. The service will match and clean up pharmacy data at the store level, deliver updates on prescribers’ licensure to the pharmacy every day, match prescriptions with providers, allow pharmacies to acquire detailed prescriber profiles and synchronize pharmacies’ prescriber databases with PrescriberPRO.


“It is crucial that pharmacies have accurate data when they fill prescriptions,” PDX-Rx.com president and CEO Jeff Farris said. “By partnering with HDS, PDX customers will have access to another cutting-edge utility that will assure the pharmacy that they are filling prescriptions for valid prescribers.”


Citing the “strong relationship” his company already has with PDX, HDS CEO Tim Slevin also hailed the potential benefits the new alliance could bring to the dispensing process. “As a leader in the pharmacy market, [PDX’s] selection of Healthcare Data Solutions’ PrescriberPRO, coupled with the power of the HDS Web Service PrescriberPRO Portal, will bring a newly developed, high-value solution to PDX customers,” he asserted.


In business for more than 25 years, PDX and its affiliates, Rx.com and the Nationwide Health Information Network, now provide automation to more than 10,000 retail pharmacies, including 14 chains and one major managed care plan. HDS specializes in compiling and distributing powerful databases on physicians, pharmacies, mid-level practitioners and dentists, with more than 2 million healthcare provider profiles.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Adults want control of their private health data

BY Alaric DeArment

AUSTIN, Texas — An overwhelming majority of respondents to a recent poll want to choose which companies and government agencies can view and use their health information.


An online survey of more than 2,000 adults conducted in November by the advocacy group Patient Privacy Rights and Zogby International — with a margin of error of plus or minus 2.2% — found that nearly all respondents favored personal control over health information, including information stored electronically. “No matter how you look at it, Americans want to control their own private health information,” Patient Privacy Rights founder Deborah Peel said. “We asked the question, ‘If you have health records in electronic systems, do you want to decide which companies and government agencies can see and use your sensitive data?’ Ninety-three percent said ‘Yes.’”


Nearly all respondents shared these sentiments; 97% said they thought doctors, hospitals, labs and health technology systems should not be allowed to share or sell health information without their consent, while 98% said insurance companies should not. Ninety-one percent of respondents said they wanted the ability to decide which individuals could see and use their information. “Americans overwhelmingly believe that they are the only people in the right position to make decisions about how their information can be used,” Peel said. “Researchers do not get a free pass.”


The results are significant considering the country’s move toward electronic health records and electronic prescribing, provisions for which were a prominent component of the American Recovery and Reinvestment Act of 2009. While supporters said the move to EHRs could save billions of dollars by reducing the risk of errors and eliminating waste, concerns about fraud and misuse of patients’ personal information have arisen as well.


Another poll, conducted online in February by Harris Interactive on behalf of Xerox — which provides a number of healthcare IT and documentation products and services — found that nearly half of the 2,180 adults surveyed were ready to give up paper medical records in favor of electronic ones and thought EHRs would lead to more efficient health care, despite many not knowing what to expect when the transition took place. A majority of respondents to the Harris poll still expressed concerns, including 79% who feared theft of records, 69% who were concerned about misuse of information and 68% who were afraid of lost or damaged records.


“Providers can ease this fear by discussing the security precautions taken to safeguard against data breaches,” Xerox VP healthcare providers John Jones said. “By arming Americans with information on EHR basics, we can prevent some of the influence of the media hype cycle around potential security risks.”


keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Sun seeks to acquire Caraco

BY Allison Cerra

DETROIT — An India-based drug maker is looking to acquire all outstanding shares of another generic drug manufacturer based in the United States.

Caraco said it received and will discuss the proposal from Sun Pharma, by which Sun would acquire all outstanding shares of common stock it doesn’t already own.

The $4.75-per-share cash transaction represents a 5% premium over the closing price of Caraco common stock on Dec. 2, Caraco said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?